In simultaneous deletion of BRCA2 and TP53, focal hyperplasia and atypical cells were observed at six months and prostatic intraepithelial neoplasia at 12 months of age [101]. The gene discussed is BRCA2; the disease is prostate intraepithelial neoplasia.